Eric H. Y. Lau - Concepedia

Author

Eric H. Y. Lau

University of Hong Kong ORCID

Also Known As

E H Lau, E H Y Lau, E Lau, E. H. Y. LAU, E. H. Y. Lau, E.H.Y. Lau, EH Lau, ERIC H. Y. LAU, Eric H.Y. Lau, Eric H Lau

416

Publications

37.4K

Citations

H-Index

113

Concepts

All Affiliations

University of Hong Kong Laboratory of Data Discovery for Health Hong Kong Science and Technology Parks Corporation Chinese University of Hong Kong Queen Mary Hospital

About

Eric H. Y. Lau is an author at University of Hong Kong specializing in medicine, epidemiology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	57	10.1K
2	Engineering	5	5	281
3	Health Sciences	2	2	101
4	Business	1	1	94
5	Management	1	1	22

Eric H. Y. Lau

173

Publications

35.9K

Citations

H-Index

Page 1

	Year	Citations
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia Qun Li, Xuhua Guan, Peng Wu, New England Journal of Medicine	2020	17.8K
Temporal dynamics in viral shedding and transmissibility of COVID-19 Xi He, Eric H. Y. Lau, Peng Wu, Nature Medicine Viral PersistenceViral DynamicVirologyCovid-19 EpidemiologyVirus Transmission	2020	4.6K
Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong Dillon C. Adam, Peng Wu, Jessica Y. Wong, Nature Medicine	2020	667
Temporal dynamics in viral shedding and transmissibility of COVID-19 Xi He, Eric H. Y. Lau, Peng Wu, Infectious Disease EpidemiologyViral PersistenceVirus EpidemiologyEmerging Infectious DiseasesLaboratory-confirmed Covid-19 Patients	2020	597
Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020 Peng Wu, Xinxin Hao, Eric H. Y. Lau, Eurosurveillance Virus EpidemiologyReal-time Tentative AssessmentCovid-19 EpidemiologyCovid-19Pathogen Discovery	2020	503
Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions Sheikh Taslim Ali, Lin Wang, Eric H. Y. Lau, Science	2020	388
Neutralizing antibody titres in SARS-CoV-2 infections Eric H. Y. Lau, Owen TY Tsang, David S.C. Hui, Nature Communications	2021	383
Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination Samuel M. S. Cheng, Chris Ka Pun Mok, Yonna W. Y. Leung, Nature Medicine VaccinationHeterologous CoronavacVaccine DevelopmentImmunologyVirology	2022	371
Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study Martina McMenamin, Joshua Nealon, Yun Lin, The Lancet Infectious Diseases VaccinationVaccinologyPopulation-based Observational StudyPreventive MedicineCovid-19 Pandemic	2022	363
Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases Benjamin J. Cowling, Lianmei Jin, Eric H. Y. Lau, The Lancet VaccinationVirus EpidemiologyComparative EpidemiologyEmergent VirusLaboratory-confirmed Cases	2013	341

Page 1